-
Exploring germline and somatic mutagenesis in the extended family with germline pathogenic variant in POLD1
Study
EGAS00001006434
-
Reliable assessment of telomere maintenance mechanisms in neuroblastoma
Study
EGAS00001006510
-
Hepatitis B virus integrations promote local and distant oncogenic driver alterations in hepatocarcinogenesis
Study
EGAS00001004629
-
Mutational landscape of eccrine porocarcinoma (sweat gland tumour)
Study
EGAS00001004632
-
Renal Cell Carcinoma Tumors From S-TRAC trial (NCT00375674) Whole Transcriptome Sequencing
Study
EGAS00001006528
-
Molecular and functional profiling of plasmablastic lymphoma
Study
EGAS00001004659
-
Clear cell sarcoma sequencing data
Study
EGAS00001006072
-
Tumour gene expression signature in primary melanoma predicts long-term outcomes: A prospective multicentre study
Study
EGAS00001004664
-
Genomic and transcriptomic analysis of baseline PDAC patients' tumors from the OXIRI phase 1b clinical trial
Study
EGAS00001006073
-
Serial assessment of measurable residual disease in medulloblastoma liquid biopsies
Study
EGAS00001005592
-
Long-read sequencing of diagnosis and post-therapy medulloblastoma reveals complex rearrangement patterns and epigenetic signatures
Study
EGAS00001006576
-
Regulatory T cell transcriptomic reprogramming characterizes adverse events by checkpoint inhibitors in solid tumors
Study
EGAS00001004694
-
Genomic abnormalities of TP53 define distinct risk groups of paediatric B-cell non-Hodgkin lymphoma
Study
EGAS00001005617
-
Whole genome sequencing of EBV Associated Nasopharyngeal Carcinoma
Study
EGAS00001004705
-
Somatic mutations predict an aggressive phenotype in meningioma but do not drive grade progression
Study
EGAS00001006585
-
A novel orthotopic patient-derived xenograft model of radiation-induced glioma following medulloblastoma
Study
EGAS00001004709
-
STAT5 is a therapeutically targetable vulnerability in cutaneous T-cell lymphoma
Study
EGAS00001004719
-
Multiomics Characterization of Low-grade Serous Ovarian Carcinoma
Study
EGAS00001004724
-
Microbiota 16S sequencing study in NSCLC patients eligible for surgery without neoadjuvant treatment
Study
EGAS00001004728
-
Multi-region whole-exome sequencing of 10 neuroblastoma cases
Study
EGAS00001004735
-
Summary statistics from genome-wide association study in glioma of 12,488 cases and 18,169 controls.
Study
EGAS00001003372
-
Mutation-specific non-canonical pathway of PTEN as a distinct therapeutic target for glioblastoma
Study
EGAS00001004753
-
Discriminating Th17.1 cell driven sarcoidosis-like inflammation from relapse after anti-BCMA CAR T cells in multiple myeloma
Study
EGAS00001006133
-
Defective homologous recombination in HCC
Study
EGAS00001006599
-
Overactivation of the IGF signalling pathway in osteosarcoma
Study
EGAS00001004767
-
RNA sequencing of multiple myeloma identifies genes dysregulated by structural variants.
Study
EGAS00001003411
-
FACS sorting of ploidy populations in an undifferentiated soft tissue sarcoma for RRBS
Study
EGAS00001006143
-
Methylation analysis of plasma DNA informs etiologies of Epstein-Barr virus-associated diseases
Study
EGAS00001003408
-
DNA and RNA sequencing data from Ovarian Carcinosarcoma patients from the Glasgow Cohort.
Study
EGAS00001006605
-
Neuroblastoma tumor heterogeneity and cell plasticity (from PDX and cell lines)
Study
EGAS00001004781
-
Rna-Seq Leiomyosarcoma subtypes
Study
EGAS00001004783
-
Comprehensive genomic and transcriptomic analysis of three synchronous primary tumours and a recurrence from a head and neck cancer patient
Study
EGAS00001004857
-
RNAseq cutaneous and uveal melanoma liver metastases
Study
EGAS00001004794
-
WES cutaneous and uveal melanoma liver metastases
Study
EGAS00001004795
-
Genomic analysis of a hypermutated gliosarcoma
Study
EGAS00001004864
-
Single_cell_characterization_of_T_cell_lymphoma_
Study
EGAS00001005750
-
Clinical genome sequencing uncovers potentially targetable truncations and fusions of MAP3K8 in spitzoid and other melanomas
Study
EGAS00001003430
-
Gut microbiome sequencing in patients receiving combination immune checkpoint blockade
Study
EGAS00001004885
-
Multi-region exome sequencing of lung adenocarcinoma precursors -1
Study
EGAS00001003439
-
Clinical impact of immune checkpoint inhibitor (ICI) response, DNA damage repair (DDR) gene mutations and immune-cell infiltration in subtypes of metastatic melanoma
Study
EGAS00001005781
-
Clonal architectures predict clinical outcome in clear cell renal cell carcinoma
Study
EGAS00001003447
-
Single-cell RNA sequencing on single CD45+ immune cells isolated from peripheral blood, lymphnode, ascites, tumour and adjacent normal tissues from six hepatocellular carcinoma patients.
Study
EGAS00001003449
-
Failure of Differentiation of the Rhombic Lip Constitutes Medulloblastoma
Study
EGAS00001005826
-
Paired data of primary and relapse central nervous system lymphoma and testicular lymphoma
Study
EGAS00001005833
-
NLG-LBC-05 ctDNA
Study
EGAS00001005835
-
Androgen receptor blockade promotes response to BRAF/MEK-targeted therapy
Study
EGAS00001006196
-
Clonal somatic copy number altered driver events inform drug sensitivity in high-grade serous ovarian cancer
Study
EGAS00001006200
-
Adenoma to Carcinoma transition in Colorectal Cancer
Study
EGAS00001003468
-
Dedifferentiated_Melanoma
Study
EGAS00001003471
-
Mutational patterns and regulatory networks in epigenetic subgroups of meningioma (H033)
Study
EGAS00001003481